Biochips and Biosensors for Health-Care and Diagnostics

A special issue of Biosensors (ISSN 2079-6374). This special issue belongs to the section "Biosensor and Bioelectronic Devices".

Deadline for manuscript submissions: 10 September 2024 | Viewed by 5271

Special Issue Editors


E-Mail Website
Guest Editor
Department of Mechanical Engineering and McMaster School of Biomedical Engineering, McMaster University, Hamilton, ON L8S 4L7, Canada
Interests: micro/nanofabrication; bioprinting; biomedical microdevices; microelectromechanical systems; microfluidics; medical and environmental sensors; smart textiles; biomaterials; artificial organs
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Bioscience and Bioengineering, Indian Institute of Technology, Bombay 400076, India
Interests: biomedical devices; electrochemical sensors; chemiresistive sensors; water quality monitoring; solid-state sensors; rapid prototyping; healthcare monitoring

Special Issue Information

Dear Colleagues,

Aging populations and infectious diseases have led to an increase in demand for point-of-care (POC) devices. Advances in microfluidics enable miniaturization and multiple biochips have been developed for the analytical detection and quantification of analytes as well as the delivery of drugs for healthcare and medical diagnostic applications.

These biochip devices use various sensing principles, including colorimetric, fluorescence, electrochemical or other novel approaches. They have conventionally been fabricated using lithography, a method which is expensive but precise. More recently, multiple rapid fabrication methods, such as xurography and 3D printing, have emerged to scale up the mass production of these devices. In addition, these devices are used in diverse applications including biosensing, on-chip separation, quantification of analytes from complex biofluids and drug discovery and delivery.

In this Special Issue, we invite authors to contribute papers focused on the design and development of novel biochips and biosensors for healthcare and medical diagnostics applications, addressing topics such as the rapid prototyping of these biochips and biosensors using newly emerging methods including xurography and 3D printing. We are also interested in covering newly emerging methods that

(1) Quantify medical diagnostics and healthcare-related analytes; 

(2) Propose separation devices for samples such as nucleic acids, proteins, metabolites, exosomes and other macrostructures;

(3) Develop devices for drug discovery, including organ on-chip devices; 

(4) Address sample pre-processing, including devices specialized to handle various biofluids; 

(5) Present devices for drug delivery and in vivo implantation.

We encourage the submission of both research articles and review articles.

Prof. Dr. P. Ravi Selvaganapathy
Dr. Vinay Patel
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biosensors is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • lab-on-chip
  • biosensors
  • rapid fabrication
  • xurography
  • 3D printing
  • electrochemical biosensors
  • colorimetric biosensors
  • fluorescence biosensors
  • biochip fabrication
  • drug delivery devices
  • in vivo implants
  • separation devices
  • organ-on-chip
  • sample pre-processing
  • biofluid handling

Published Papers (4 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

15 pages, 4265 KiB  
Article
Advancing Point-of-Care Diagnosis: Digitalizing Combinatorial Biomarker Signals for Lupus Nephritis
by Jiechang Guo, Aygun Teymur, Chenling Tang, Ramesh Saxena and Tianfu Wu
Biosensors 2024, 14(3), 147; https://doi.org/10.3390/bios14030147 - 18 Mar 2024
Viewed by 837
Abstract
To improve the efficiency and patient coverage of the current healthcare system, user-friendly novel homecare devices are urgently needed. In this work, we developed a smartphone-based analyzing and reporting system (SBARS) for biomarker detection in lupus nephritis (LN). This system offers a cost-effective [...] Read more.
To improve the efficiency and patient coverage of the current healthcare system, user-friendly novel homecare devices are urgently needed. In this work, we developed a smartphone-based analyzing and reporting system (SBARS) for biomarker detection in lupus nephritis (LN). This system offers a cost-effective alternative to traditional, expensive large equipment in signal detection and quantification. This innovative approach involves using a portable and affordable microscopic reader to capture biomarker signals. Through smartphone-based image processing techniques, the intensity of each biomarker signal is analyzed. This system exhibited comparable performance to a commercial Genepix scanner in the detection of two potential novel biomarkers of LN, VISG4 and TNFRSF1b. Importantly, this smartphone-based analyzing and reporting system allows for discriminating LN patients with active renal disease from healthy controls with the area-under-the-curve (AUC) value = 0.9 for TNFRSF1b and 1.0 for VSIG4, respectively, indicating high predictive accuracy. Full article
(This article belongs to the Special Issue Biochips and Biosensors for Health-Care and Diagnostics)
Show Figures

Figure 1

10 pages, 3096 KiB  
Communication
The Quantitative Detection of Cystatin-C in Patient Samples Using a Colorimetric Lateral Flow Immunoassay
by Santosh Kumar Bikkarolla, Kavipriya Venkatesan, Yeddula Rebecca Revathy, Sowmya Parameswaran, Subramanian Krishnakumar and Dhananjaya Dendukuri
Biosensors 2024, 14(1), 30; https://doi.org/10.3390/bios14010030 - 08 Jan 2024
Viewed by 1443
Abstract
A colloidal gold-based lateral flow immunoassay was developed for the rapid quantitative detection of Cystatin-C in serum and whole blood. This device has an assay time of 15 min, making it a convenient point-of-care diagnostic tool. The device has a quantification range spanning [...] Read more.
A colloidal gold-based lateral flow immunoassay was developed for the rapid quantitative detection of Cystatin-C in serum and whole blood. This device has an assay time of 15 min, making it a convenient point-of-care diagnostic tool. The device has a quantification range spanning from 0.5 to 7.5 µg/mL, with a lower limit of detection at 0.18 µg/mL. To validate its accuracy, the test was compared to a standard nephelometric immunoassay, and the results exhibited a robust linear correlation with an adjusted r2 value of 0.95. Furthermore, the device demonstrates satisfactory levels of analytical performance in terms of precision, sensitivity, and interference, indicating its potential for precise Cystatin-C quantification, particularly in renal-failure patients. Notably, the Cystatin-C-LFA device also demonstrates satisfactory stability, as a 30-day accelerated stability study at 50 °C showed no change in the device performance, indicating a long shelf life for the product when stored at room temperature. Full article
(This article belongs to the Special Issue Biochips and Biosensors for Health-Care and Diagnostics)
Show Figures

Figure 1

13 pages, 2931 KiB  
Article
A Facile Method for the Fabrication of the Microneedle Electrode and Its Application in the Enzymatic Determination of Glutamate
by Mahmoud Amouzadeh Tabrizi
Biosensors 2023, 13(8), 828; https://doi.org/10.3390/bios13080828 - 18 Aug 2023
Cited by 2 | Viewed by 1401
Abstract
Herein, a simple method has been used in the fabrication of a microneedle electrode (MNE). To do this, firstly, a commercial self-dissolving microneedle patch has been used to make a hard-polydimethylsiloxane-based micro-pore mold (MPM). Then, the pores of the MPM were filled with [...] Read more.
Herein, a simple method has been used in the fabrication of a microneedle electrode (MNE). To do this, firstly, a commercial self-dissolving microneedle patch has been used to make a hard-polydimethylsiloxane-based micro-pore mold (MPM). Then, the pores of the MPM were filled with the conductive platinum (Pt) paste and cured in an oven. Afterward, the MNE made of platinum (Pt-MNE) was characterized using cyclic voltammetry (CV), electrochemical impedance spectroscopy (EIS), and scanning electron microscopy (SEM). To prove the electrochemical applicability of the Pt-MNE, the glutamate oxidase enzyme was immobilized on the surface of the electrode, to detect glutamate, using the cyclic voltammetry (CV) and chronoamperometry (CA) methods. The obtained results demonstrated that the fabricated biosensor could detect a glutamate concentration in the range of 10–150 µM. The limits of detection (LODs) (three standard deviations of the blank/slope) were also calculated to be 0.25 µM and 0.41 µM, using CV and CA, respectively. Furthermore, the Michaelis–Menten constant (KMapp) of the biosensor was calculated to be 296.48 µM using a CA method. The proposed biosensor was finally applied, to detect the glutamate concentration in human serum samples. The presented method for the fabrication of the mold signifies a step further toward the fabrication of a microneedle electrode. Full article
(This article belongs to the Special Issue Biochips and Biosensors for Health-Care and Diagnostics)
Show Figures

Figure 1

12 pages, 2102 KiB  
Article
Simultaneous Determination of Uric Acid and Caffeine by Flow Injection Using Multiple-Pulse Amperometry
by Ademar Wong, Anderson M. Santos, Maria H. A. Feitosa, Orlando Fatibello-Filho, Fernando C. Moraes and Maria D. P. T. Sotomayor
Biosensors 2023, 13(7), 690; https://doi.org/10.3390/bios13070690 - 29 Jun 2023
Cited by 1 | Viewed by 1008
Abstract
The present study reports the development and application of a flow injection analysis (FIA) system for the simultaneous determination of uric acid (UA) and caffeine (CAF) using cathodically pretreated boron-doped diamond electrode (CPT-BDD) and multiple-pulse amperometry (MPA). The electrochemical profiles of UA and [...] Read more.
The present study reports the development and application of a flow injection analysis (FIA) system for the simultaneous determination of uric acid (UA) and caffeine (CAF) using cathodically pretreated boron-doped diamond electrode (CPT-BDD) and multiple-pulse amperometry (MPA). The electrochemical profiles of UA and CAF were analyzed via cyclic voltammetry in the potential range of 0.20–1.7 V using 0.10 mol L−1 H2SO4 solution as supporting electrolyte. Under optimized conditions, two oxidation peaks at potentials of 0.80 V (UA) and 1.4 V (CAF) were observed; the application of these potentials using multiple-pulse amperometry yielded concentration linear ranges of 5.0 × 10−8–2.2 × 10−5 mol L−1 (UA) and 5.0 × 10−8–1.9 × 10−5 mol L−1 (CAF) and limits of detection of 1.1 × 10−8 and 1.3 × 10−8 mol L−1 for UA and CAF, respectively. The proposed method exhibited good repeatability and stability, and no interference was detected in the electrochemical signals of UA and CAF in the presence of glucose, NaCl, KH2PO4, CaCl2, urea, Pb, Ni, and Cd. The application of the FIA-MPA method for the analysis of environmental samples resulted in recovery rates ranging between 98 and 104%. The results obtained showed that the BDD sensor exhibited a good analytical performance when applied for CAF and UA determination, especially when compared to other sensors reported in the literature. Full article
(This article belongs to the Special Issue Biochips and Biosensors for Health-Care and Diagnostics)
Show Figures

Figure 1

Back to TopTop